Got a huge TAM (Total Addressable Market) with this.
The heart failure addressable market being quadruple that of aortic stenosis is even crazier.
Positive future both short term (FDA approval and commercialisation) and long term (further commercialistation and heart failure analysis).
Ann: Quarterly Activities Report and Appendix 4C Cash Flow Report, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
23.3¢ |
Change
0.003(1.09%) |
Mkt cap ! $151.6M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 23.5¢ | 23.0¢ | $58.87K | 254.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 694895 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 247485 | 10 |
View Market Depth
| Last trade - 12.44pm 23/07/2025 (20 minute delay) ? |
| EIQ (ASX) Chart |